1. Dennis, T., Curet, O., Nishikawa, T., and Scatton, B. 1985.
Further evidence for, and nature of, the facilitatory GABAergic 20.
influence on central noradrenergic transmission. Naunyn
Schmiedebergs Arch. Pharmacol. 331:225–234.
2. Scatton, B., Lloyd, K. G., Zivkovic, B., Dennis, T., Claustre, Y.,
Dedek, J., Arbilla, S., Langer, S. Z., and Bartholini, G. 1987. 21.
Fengabine, a novel antidepressant GABAergic agent. II. Effect
on cerebral noradrenergic, serotonergic and GABAergic transmission in the rat. J. Pharmacol. Exp. Ther. 241:251–257.
3. Fuchs, E., Mansky, T., Stock, K. W., Vijayan, E., and Wuttke, 22.
W. 1984. Involvement of catecholamines and glutamate in
GABAergic mechanism regulatory to luteinizing hormone and
prolactin secretion. Neuroendocrinol. 38:484 – 489. 23.
4. Adler, B. A. and Crowley, W. R. 1986. Evidence for gammaaminobutyric acid modulation of ovarian hormonal effects on
luteinizing hormone secretion and hypothalamic catecholamine 24.
activity in the female rat. Endocrinol. 118:91–97.
